RSS

haemophilia A

The European Commission (EC) has approved Roche’s routine prophylactic treatment in people with haemophilia A with factor VIII inhibitors, Hemlibra (emicizumab). more

News

The EU Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Hemlibra (emicizumab) — Roche’s prophylactic treatment for people with haemophilia A with inhibitors. more

News

Biotech company, Roche, has announced that the US FDA has accepted its biologics licence application (BLA) and granted priority review for its once-weekly subcutaneous treatment for haemophilia A with factor VIII inhibitors more

News

A capsule has been developed that can treat people affected by the hereditary bleeding disorder haemophilia. more

News

The latest interim data from the guardian2 extension trial for Novo Nordisk NovoEight showed that in a phase 3 trial, long-term efficacy and safety in the prophylaxis and treatment of bleeds was achieved in people with severe haemophilia A. more

News